Skip to main content

Table 3 Correlation of CD4+ and FOXP3+ TILs with hormone receptor and her2/neu status in ductal carcinomas

From: Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers

Compartment/TIL subtype

ER status

PR status

Her2/neu

 

-

+

p-value

-

+

p-value

-

+

p-value

Total

         

CD4 +

25.1 ± 29.7

15.6 ± 22.9

< 0.001

12.4 ± 19.3

17.9 ± 25.2

0.008

17.0 ± 24.5

22.4 ± 27.4

0.023

FOXP3 +

11.9 ± 16.1

6.9 ± 11.3

< 0.001

8.6 ± 13.4

6.7 ± 10.9

0.203

7.6 ± 12.6

10.6 ± 13.0

< 0.001

Intratumoral

         

CD4 +

17.5 ± 23.4

10.7 ± 18.5

< 0.001

8.2 ± 13.6

12.7 ± 21.6

0.032

11.7 ± 19.7

15.6 ± 21.8

0.036

FOXP3 +

7.0 ± 12.8

3.0 ± 7.0

< 0.001

4.0 ± 9.2

2.7 ± 6.1

0.12

3.7 ± 8.7

4.7 ± 8.1

0.009

  1. Mean ± SD, counts of immunoreactive lymphocytes CD4+ and FOXP3+ Wilcoxon Rank Sum Test; *after adjustment for multiple comparisons, only p < 0.001 was considered statistically significant